Johnson & Johnson · Moat analysis

Report previewJNJ.USReport date Last updated
← Back to examples
Report contents

Historical report · Original report date 2026-01-07. This is previously published source-report content.

Generated by DeepVal AI. Data and models may contain errors or be outdated. For research only; not personalized investment advice.

01

Comparison scope

Medicines and medical technology; selected historical passages

02

Competitive advantages

The selected passages identify advantages in patents and clinical integration.

Innovation and clinical integration

Patent protection supports differentiated medicines. Clinical training, evidence, and established workflows can increase the effort involved in switching medical products.

Durability depends on replacing products as patents expire and maintaining clinical relevance.